TY - JOUR
TI - Lanadelumab for hereditary angioedema
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2022
ET - 2022/03/04
VL - 45
IS - 2
DO - 10.18773/austprescr.2022.017
LA - eng
UR - https://australianprescriber.tg.org.au/articles/lanadelumab-for-hereditary-angioedema.html
KW - hereditary angioedema
KW - lanadelumab
KW - Takhzyro
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -